Business Context and Reporting Period
This Form 6-K filing by CollPlant Biotechnologies Ltd. is dated April 7, 2020. The report serves to notify shareholders of an upcoming Extraordinary General Meeting scheduled for May 14, 2020, in Tel-Aviv, Israel.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding a shareholder meeting and does not contain financial statements or performance data.
Material Changes
No material financial changes versus prior periods are reported in this filing. The primary update is the scheduling of a corporate governance event.
Guidance, Outlook, and Corporate Actions
- Shareholder Meeting: An Extraordinary General Meeting will be held on May 14, 2020, at 10:00 a.m. Israel time at the offices of Gross, Kleinhendler, Hodak, Halevy, Greenberg, Shenhav & Co. in Tel-Aviv.
- Voting Materials: The filing includes a Notice and Proxy Statement (Exhibit 99.1), a Proxy Card for ordinary share holders (Exhibit 99.2), and a Voting Instruction Card for ADS holders (Exhibit 99.3).
- Plan Update: An updated Share Ownership and Option Plan (2010) is attached as Exhibit 99.4.
Key Facts for Investor Verification
- Verify the specific proposals to be voted upon in the attached Notice and Proxy Statement (Exhibit 99.1).
- Confirm the record date and voting procedures for both ordinary shares and ADSs.
- Review the updated Share Ownership and Option Plan (Exhibit 99.4) for any changes to equity incentive structures.